Nanhua Bio Medicine Co Ltd (000504) - Total Assets
Based on the latest financial reports, Nanhua Bio Medicine Co Ltd (000504) holds total assets worth CN¥881.23 Million CNY (≈ $128.95 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nanhua Bio Medicine Co Ltd - Total Assets Trend (1989–2025)
This chart illustrates how Nanhua Bio Medicine Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Nanhua Bio Medicine Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.
Nanhua Bio Medicine Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Nanhua Bio Medicine Co Ltd's total assets of CN¥881.23 Million consist of 74.5% current assets and 25.5% non-current assets. Review 000504 total debt and obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 35.0% |
| Accounts Receivable | CN¥218.52 Million | 22.0% |
| Inventory | CN¥18.67 Million | 1.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥55.81 Million | 5.6% |
| Goodwill | CN¥6.23 Million | 0.6% |
Asset Composition Trend (1989–2025)
This chart illustrates how Nanhua Bio Medicine Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 000504 stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nanhua Bio Medicine Co Ltd's current assets represent 74.5% of total assets in 2025, an increase from 29.8% in 1989.
- Cash Position: Cash and equivalents constituted 35.0% of total assets in 2025, up from 4.4% in 1989.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 0.0% in 1989.
- Asset Diversification: The largest asset category is accounts receivable at 22.0% of total assets.
Nanhua Bio Medicine Co Ltd Competitors by Total Assets
Key competitors of Nanhua Bio Medicine Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Tubize-Fin
BR:TUB
|
Belgium | €1.99 Billion |
|
Dianthus Therapeutics Inc.
NASDAQ:DNTH
|
USA | $1.21 Billion |
|
Tango Therapeutics Inc
NASDAQ:TNGX
|
USA | $1.07 Billion |
|
Damora Therapeutics, Inc.
NASDAQ:DMRA
|
USA | $543.64 Million |
|
Apnimed, Inc. Common Stock
NASDAQ:APMD
|
USA | $342.63 Million |
|
Wecome Pharmaceutical Co Ltd
SHE:300878
|
China | CN¥1.49 Billion |
|
Tectonic Therapeutic, Inc.
NASDAQ:TECX
|
USA | $246.58 Million |
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
USA | $235.36 Million |
Nanhua Bio Medicine Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.45 | 1.58 | 1.09 |
| Quick Ratio | 1.33 | 1.52 | 1.06 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥197.60 Million | CN¥178.24 Million | CN¥41.63 Million |
Nanhua Bio Medicine Co Ltd - Advanced Valuation Insights
This section examines the relationship between Nanhua Bio Medicine Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.44 |
| Latest Market Cap to Assets Ratio | 0.49 |
| Asset Growth Rate (YoY) | 63.1% |
| Total Assets | CN¥991.73 Million |
| Market Capitalization | $483.41 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nanhua Bio Medicine Co Ltd's assets below their book value (0.49x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Nanhua Bio Medicine Co Ltd's assets grew by 63.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Nanhua Bio Medicine Co Ltd (1989–2025)
The table below shows the annual total assets of Nanhua Bio Medicine Co Ltd from 1989 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥991.73 Million ≈ $145.12 Million |
+63.07% |
| 2024-12-31 | CN¥608.17 Million ≈ $88.99 Million |
-21.16% |
| 2023-12-31 | CN¥771.38 Million ≈ $112.88 Million |
+39.47% |
| 2022-12-31 | CN¥553.06 Million ≈ $80.93 Million |
-16.11% |
| 2021-12-31 | CN¥659.25 Million ≈ $96.47 Million |
+18.54% |
| 2020-12-31 | CN¥556.14 Million ≈ $81.38 Million |
+107.26% |
| 2019-12-31 | CN¥268.33 Million ≈ $39.27 Million |
-21.70% |
| 2018-12-31 | CN¥342.71 Million ≈ $50.15 Million |
-15.33% |
| 2017-12-31 | CN¥404.78 Million ≈ $59.23 Million |
+34.39% |
| 2016-12-31 | CN¥301.19 Million ≈ $44.07 Million |
+145.35% |
| 2015-12-31 | CN¥122.76 Million ≈ $17.96 Million |
+15.12% |
| 2014-12-31 | CN¥106.63 Million ≈ $15.60 Million |
-15.30% |
| 2013-12-31 | CN¥125.89 Million ≈ $18.42 Million |
+65.52% |
| 2012-12-31 | CN¥76.06 Million ≈ $11.13 Million |
-72.49% |
| 2011-12-31 | CN¥276.47 Million ≈ $40.46 Million |
-3.61% |
| 2010-12-31 | CN¥286.82 Million ≈ $41.97 Million |
-30.42% |
| 2009-12-31 | CN¥412.24 Million ≈ $60.32 Million |
-23.16% |
| 2008-12-31 | CN¥536.52 Million ≈ $78.51 Million |
-21.25% |
| 2007-12-31 | CN¥681.31 Million ≈ $99.70 Million |
+6.88% |
| 2006-12-31 | CN¥637.48 Million ≈ $93.28 Million |
-1.63% |
| 2005-12-31 | CN¥648.02 Million ≈ $94.83 Million |
+7.31% |
| 2004-12-31 | CN¥603.88 Million ≈ $88.37 Million |
+1.37% |
| 2003-12-31 | CN¥595.75 Million ≈ $87.18 Million |
-3.92% |
| 2002-12-31 | CN¥620.07 Million ≈ $90.74 Million |
+3.18% |
| 2001-12-31 | CN¥600.98 Million ≈ $87.94 Million |
+0.66% |
| 2000-12-31 | CN¥597.05 Million ≈ $87.37 Million |
+24.52% |
| 1999-12-31 | CN¥479.49 Million ≈ $70.16 Million |
-24.02% |
| 1998-12-31 | CN¥631.05 Million ≈ $92.34 Million |
-15.17% |
| 1997-12-31 | CN¥743.86 Million ≈ $108.85 Million |
-3.01% |
| 1996-12-31 | CN¥766.94 Million ≈ $112.23 Million |
-10.93% |
| 1995-12-31 | CN¥861.03 Million ≈ $126.00 Million |
+3.60% |
| 1994-12-31 | CN¥831.10 Million ≈ $121.62 Million |
+6.23% |
| 1993-12-31 | CN¥782.34 Million ≈ $114.48 Million |
+71.85% |
| 1992-12-31 | CN¥455.24 Million ≈ $66.62 Million |
+103.77% |
| 1991-12-31 | CN¥223.41 Million ≈ $32.69 Million |
+168.59% |
| 1990-12-31 | CN¥83.18 Million ≈ $12.17 Million |
+337.63% |
| 1989-12-31 | CN¥19.01 Million ≈ $2.78 Million |
-- |
About Nanhua Bio Medicine Co Ltd
Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. It operates in two segments, Biomedicine, and Energy Saving and Environmental Protection. The Biomedicine segment provides stem cell and immune cell testing, storage, and technical services; as well as sales of biopharmaceutical products, such as beauty products, health supplements, and air purifiers. The Energy Saving and… Read more